艾昆纬-中国医疗技术市场导航（英）-2025_11页_4mb

China's MedTech market is the world's second-largest, presenting opportunities amid complexities. Financial pressures from public medical insurance funding have driven reforms like Volume-Based Procurement (VBP) to reduce costs. VBP scope has expanded geographically and to various products, including high-value consumables, low-value items, and IVDs, with price cuts raising concerns about quality in recent price reductions. Innovation and commercial insurance support growing opportunities in private healthcare. MedTech firms can thrive by adopting strategies such as localizing supply chains, investing in R&D, forming collaborations, and monitoring market changes, navigating regulatory shifts and cost-control measures effectively.